Stroke and acute Myocardial Infarction in the Thrombolytic era: Clinical correlates and long-term prognosis
- 30 September 1990
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 16 (3), 533-540
- https://doi.org/10.1016/0735-1097(90)90338-p
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionThe New England Journal of Medicine, 1989
- A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction.Circulation, 1989
- Administration of thrombolytic therapy in the community hospital: Established principles and unresolved issuesJournal of the American College of Cardiology, 1988
- Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.BMJ, 1988
- TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction.Circulation, 1988
- A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionThe New England Journal of Medicine, 1987
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)The New England Journal of Medicine, 1986
- Myocardial infarction and strokeNeurology, 1984
- Stroke after acute myocardial infarction: relation to infarct size.BMJ, 1978